Fatal fulminant legionnaires' disease in a patient with severe erythodermic psoriasis treated with infliximab after long-term steroid therapy.
Eisendle
K
K
Fritsch
P
P
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003879:Dermatologic Agents / Q000009:adverse effects*; D017809:Fatal Outcome; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D007877:Legionnaires' Disease / Q000139:chemically induced*; D008297:Male; D008875:Middle Aged; D009894:Opportunistic Infections / Q000139:chemically induced; D011239:Prednisolone / Q000009:adverse effects / Q000627:therapeutic use; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D005938:Glucocorticoids; D011239:Prednisolone; D000069285:Infliximab